{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:33:45Z","timestamp":1781163225936,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005468","name":"Batten Disease Support and Research Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005468","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cca.2020.04.010","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T01:49:02Z","timestamp":1586742542000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Diagnosis of late-infantile neuronal ceroid lipofuscinosis using dried blood spot-based assay for TPPI enzyme activity"],"prefix":"10.1016","volume":"507","author":[{"given":"Maureen","family":"Gavin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha","family":"Khatoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine J.","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford A.","family":"Mevs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milen T.","family":"Velinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Junaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.04.010_b0005","unstructured":"M. Gavin, M.T. Velinov, E. Dockter, Battling Batten disease; rarely diagnosed immediately, the disease leads to inevitable deterioration, [Internet] [King of Prussia (PA): Merion Matters] Advance for Nurses (2010). http:\/\/nursing.advanceweb.com\/, (accessed January 2, 2020)."},{"key":"10.1016\/j.cca.2020.04.010_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","article-title":"Batten disease: past, present, and future","volume":"5","author":"Rider","year":"1988","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"10.1016\/j.cca.2020.04.010_b0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0387-7604(88)80075-5","article-title":"Neuronal ceroid- lipofuscinoses in childhood","volume":"10","author":"Santavuori","year":"1988","journal-title":"Brain Dev."},{"key":"10.1016\/j.cca.2020.04.010_b0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","article-title":"Lysosomal storage diseases\u2212the horizon expands","volume":"9","author":"Boustany","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2020.04.010_b0025","unstructured":"Batten Disease Fact Sheet, NINDS, NIH, https:\/\/www.ninds.nih.gov\/Disorders\/Patient-Caregiver-Education\/Fact-Sheets\/Batten-Disease-Fact-Sheet\/, 2020 (accessed January 2, 2020)."},{"key":"10.1016\/j.cca.2020.04.010_b0030","unstructured":"S.E. Mole, R.E. Williams, Neuronal Ceroid Lipofuscinosis, in: M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, A. Amemiya, (Eds.), Source GeneReviews\u00ae [Internet], University of Washington, Seattle, Seattle (WA), 1993\u22122019, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1428\/ (accessed January 2, 2020)."},{"issue":"10 Pt B","key":"10.1016\/j.cca.2020.04.010_b0035","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease),","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.cca.2020.04.010_b0040","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1086\/302427","article-title":"Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder","volume":"64","author":"Sleat","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.cca.2020.04.010_b0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.gene.2012.12.058","article-title":"Neuronal ceroid lipofuscinosis type CLN2: a new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America","volume":"516","author":"Kohan","year":"2013","journal-title":"Gene"},{"issue":"20","key":"10.1016\/j.cca.2020.04.010_b0050","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"CLN2 Study Group, study of intraventricular cerliponase Alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cca.2020.04.010_b0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.cca.2020.04.010_b0060","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/humu.23860","article-title":"Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease","volume":"40","author":"Gardner","year":"2019","journal-title":"Hum. Mutat."},{"issue":"1\u20132","key":"10.1016\/j.cca.2020.04.010_b0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2016.07.011","article-title":"Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis","volume":"119","author":"Fietz","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.cca.2020.04.010_b0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0301-2115(98)00333-9","article-title":"A novel assay for lysosomal pepstatin-insensitive proteinase and its application for the diagnosis of late-infantile neuronal ceroid lipofuscinosis","volume":"281","author":"Junaid","year":"1999","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.cca.2020.04.010_b0075","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1373\/49.3.509","article-title":"Rapid and simple assay for the determination of tripeptidyl peptidase and palmitoyl protein thioesterase activities in dried blood spots","volume":"49","author":"Lukacs","year":"2003","journal-title":"Clin. Chem."},{"issue":"15","key":"10.1016\/j.cca.2020.04.010_b0080","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1021\/ac501994b","article-title":"Tandem mass spectrometry assays of palmitoyl protein thioesterase 1 and tripeptidyl peptidase activity in dried blood spots for the detection of neuronal ceroid lipofuscinoses in newborns","volume":"86","author":"Barcenas","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2020.04.010_b0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cca.2019.02.010","article-title":"Validity of a rapid and simple fluorometric tripeptidyl peptidase 1 (TPP1) assay using dried blood specimens to diagnose CLN2 disease","volume":"492","author":"Lukacs","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"1\u20133","key":"10.1016\/j.cca.2020.04.010_b0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(99)00095-6","article-title":"Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases","volume":"264","author":"Junaid","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.cca.2020.04.010_b0095","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1515\/hsz-2019-0103","article-title":"The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts","volume":"400","author":"Ivry","year":"2019","journal-title":"Biol. Chem."},{"issue":"Suppl A","key":"10.1016\/j.cca.2020.04.010_b0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/ejpn.2000.0460","article-title":"Pre- and postnatal enzyme analysis for infantile, late infantile and adult neuronal ceroid lipofuscinosis (CLN1 and CLN2)","volume":"5","author":"van Diggelen","year":"2001","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"2","key":"10.1016\/j.cca.2020.04.010_b0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(98)01683-4","article-title":"Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I","volume":"443","author":"Vines","year":"1999","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.cca.2020.04.010_b0110","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1373\/clinchem.2016.269167","article-title":"Multiplex tandem mass spectrometry enzymatic activity assay for newborn screening of the mucopolysaccharidoses and type 2 neuronal ceroid lipofuscinosis","volume":"63","author":"Liu","year":"2017","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.cca.2020.04.010_b0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1570-0232(02)00914-5","article-title":"Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry","volume":"785","author":"Polson","year":"2003","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.cca.2020.04.010_b0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cca.2020.04.010_b0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1471-4159.2000.0740287.x","article-title":"Purification and characterization of bovine brain lysosomal pepstatin-insensitive proteinase, the gene product deficient in the human late-infantile neuronal ceroid lipofuscinosis","volume":"74","author":"Junaid","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2020.04.010_b0130","doi-asserted-by":"crossref","unstructured":"American College of Medical Genetics Newborn Screening Expert Group, Newborn screening: toward a uniform screening panel and system\u2212executive summary, Pediatrics 117(5 Pt 2) (2006) S296\u2212307.","DOI":"10.1542\/peds.2005-2633I"},{"issue":"5","key":"10.1016\/j.cca.2020.04.010_b0135","doi-asserted-by":"crossref","first-page":"1631S","DOI":"10.1093\/jn\/131.5.1631S","article-title":"Use of filter paper for the collection and analysis of human whole blood specimens","volume":"131","author":"Mei","year":"2001","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.cca.2020.04.010_b0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ymgme.2018.03.007","article-title":"Characteristics of PPT1 and TPP1 enzymes in neuronal ceroid lipofuscinosis (NCL) 1 and 2 by dried blood spots (DBS) and leukocytes and their application to newborn screening","volume":"124","author":"Itagaki","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.cca.2020.04.010_b0145","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinchem\/46.7.1005","article-title":"Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays","volume":"46","author":"Sohar","year":"2000","journal-title":"Clin. Chem."},{"issue":"5333","key":"10.1016\/j.cca.2020.04.010_b0150","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cca.2020.04.010_b0155","unstructured":"National Center for Biotechnology Information. ClinVar; [VCV000002644.4] (2019). https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/2644\/, (accessed January 2, 2020)."},{"issue":"3","key":"10.1016\/j.cca.2020.04.010_b0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1399-0004.1998.tb04291.x","article-title":"Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis","volume":"54","author":"Zhong","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.cca.2020.04.010_b0165","unstructured":"National Center for Biotechnology Information. ClinVar; [198725] (2018). https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/198725\/, (accessed January 2, 2020)."},{"issue":"1","key":"10.1016\/j.cca.2020.04.010_b0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum. Mutat."},{"issue":"3\u20134","key":"10.1016\/j.cca.2020.04.010_b0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10048-013-0375-8","article-title":"Diagnostic utility of whole exome sequencing in patients showing cerebellar and\/or vermis atrophy in childhood","volume":"14","author":"Ohba","year":"2013","journal-title":"Neurogenetics"},{"issue":"2","key":"10.1016\/j.cca.2020.04.010_b0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/172460080001500201","article-title":"A lysosomal pepstatin-insensitive proteinase as a novel biomarker for breast carcinoma","volume":"15","author":"Junaid","year":"2000","journal-title":"Int. J. Biol. Markers"},{"issue":"3","key":"10.1016\/j.cca.2020.04.010_b0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnen\/60.3.280","article-title":"Distribution of tripeptidyl peptidase I in human tissues under normal and pathological conditions","volume":"60","author":"Kida","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.010_b0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3892\/or.2016.5240","article-title":"The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma","volume":"37","author":"Zhao","year":"2017","journal-title":"Oncol. Rep."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120301650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120301650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:52:50Z","timestamp":1757861570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120301650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"alternative-id":["S0009898120301650"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.04.010","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of late-infantile neuronal ceroid lipofuscinosis using dried blood spot-based assay for TPPI enzyme activity","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}